Patent Assignment
Reel/Frame 023861/0740
Merger
Recorded: 2010-01-28
Pages: 8
Assignor
VALEANT RESEARCH & DEVELOPMENT
Executed: 2006-12-29
Assignee
VALEANT PHARMACEUTICALS NORTH AMERICA
ONE ENTERPRISE, ALISO VIEJO, CALIFORNIA, 92656
Covered Properties
(3)
Sugar Modified Nucleosides and Their Use for Synthesis of Oligonucleotides
Patent:
5,712,378 →
Application:
08/552,363 →
Sugar Modified Nucleosides
Patent:
6,191,266 →
Application:
08/766,991 →
Sugar Modified Nucleosides
Patent:
6,743,902 →
Application:
09/697,545 →
Related Assignments
(7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 2, 1995
From: WANG, GUANGYI
To: ICN PHARMACEUTICALS
Reel/Frame 007952/0854 →
Contribution Agreement
Mar 27, 2005
From: ICN PHARMACEUTICALS, INC.
To: RIBAPHARM INC.
Reel/Frame 015819/0595 →
Change of Name
Aug 24, 2005
From: RIBAPHARM INC.
To: VALEANT RESEARCH & DEVELOPMENT
Reel/Frame 016446/0026 →
Assignment of Assignor's Interest
Apr 14, 2010
From: VALEANT PHARMACEUTICALS INTERNATIONAL
To: MDRNA, INC.
Reel/Frame 024233/0034 →
Security Agreement (Patents)
Apr 28, 2010
From: MDRNA, INC. FKA NASTECH PHARMACEUTICAL COMPANY INC.
To: CEQUENT PHARMACEUTICALS, INC.
Reel/Frame 024300/0825 →
Release of Security Interest
Jul 30, 2010
From: CEQUENT PHARMACEUTICALS, INC.
To: MARINA BIOTECH, INC. (F/K/A MDRNA, INC.)
Reel/Frame 024767/0466 →
Change of Name
Jun 27, 2011
From: MDRNA, INC.
To: MARINA BIOTECH, INC.
Reel/Frame 026509/0166 →